SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 18.38
-0.38 (-2.00%)
Jun 9, 2025, 4:35 PM GMT+1
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 42.81 million as of June 9, 2025. Its market cap has increased by 122.04% in one year.
Market Cap
42.81M
Enterprise Value
42.60M
Revenue
2.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.38
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 42.81M, an increase of 172.17%. That is a compound annual growth rate of 13.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.19B |
| GSK plc | 61.32B |
| Haleon | 36.46B |
| Smith & Nephew | 9.84B |
| ConvaTec Group | 6.04B |
| Hikma Pharmaceuticals | 4.69B |
| HUTCHMED (China) | 1.92B |
| Genus | 1.31B |